Against synthetic Anthrax LF corresponding to amino acids 779-792 of Bacillus anthracis origin.
Key Feature
Clonality
monoclonal
Isotype
IgG1
Host Species
Mouse
Tested Applications
WB
WB:1:100-1:1000
Predicted Reactivity
Bacillus anthracis
Concentration
0.1mg/ml
Purification
Affinity purified
Target Information
Gene Symbol
lef
Gene Full Name
anthrax toxin lethal factor
Molecular Weight(MW)
93kDa
Function
The genus Bacillus consists of aerobic, Gram-positive, spore-forming, rod shaped bacterium. Bacillus anthracis causes anthrax, an acute infectious disease of cattle, sheep, goats, camels, antelopes and other herbivores that is highly lethal in some forms. B. anthracis spores can persist in the soil for many years as they are resistant to heat, cold, radiation, desiccation and disinfectants. The anthrax toxin produced by Bacillus anthracis has two components: edema factor (EF) and lethal factor (LF). The EF inactivates neutrophils so that they cannot phagocytose bacteria, and the LF, a zinc dependent metalloprotease, cleaves the mitogen activated protein kinase kinase (MAPKK) enzymes of the MAPK signaling pathway, thereby impairing their function. The overall result is an impaired innate and adaptive immune response with an overproduction of TNF-α and interleukin-1-β, ultimately leading to septic shock and death. The anthrax lethal factor also targets endothelial cells, causing vascular leakage and ultimately hypovolemic shock.
Application
WB
WB analysis of recombinant anthrax LF protein using Anthrax LF antibody.
Application Notes
WB:1:100-1:1000
Additional Information
Form
Liquid
Storage Instructions
Store at 4° C, **DO NOT FREEZE**. Stable for one year from the date of shipment. Non-hazardous. No MSDS required.
Storage Buffer
Each vial contains 100 µg IgG1 in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin.